Immunovant
IMVT
IMVT
115 hedge funds and large institutions have $1.37B invested in Immunovant in 2020 Q3 according to their latest regulatory filings, with 39 funds opening new positions, 53 increasing their positions, 20 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
32% more funds holding
Funds holding: 87 → 115 (+28)
2% more ownership
Funds ownership: 43.23% → 45.23% (+2%)
Holders
115
Holding in Top 10
6
Calls
–
Puts
–
Top Buyers
| 1 | +$63.1M | |
| 2 | +$57.6M | |
| 3 | +$52.5M | |
| 4 |
Point72 Asset Management
Stamford,
Connecticut
|
+$48M |
| 5 |
BlackRock
New York
|
+$43.2M |
Top Sellers
| 1 | -$37.3M | |
| 2 | -$16.9M | |
| 3 | -$15.2M | |
| 4 |
CCM
Camber Capital Management
Boston,
Massachusetts
|
-$12.7M |
| 5 |
O
OrbiMed
New York
|
-$8.63M |